Compare IPI & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPI | SLDB |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 380.0M | 444.9M |
| IPO Year | 2008 | 2018 |
| Metric | IPI | SLDB |
|---|---|---|
| Price | $28.21 | $5.84 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $23.00 | $14.82 |
| AVG Volume (30 Days) | 138.4K | ★ 910.5K |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $222,728,000.00 | N/A |
| Revenue This Year | $23.99 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.93 | N/A |
| 52 Week Low | $20.86 | $2.41 |
| 52 Week High | $39.01 | $7.37 |
| Indicator | IPI | SLDB |
|---|---|---|
| Relative Strength Index (RSI) | 62.49 | 55.93 |
| Support Level | $26.04 | $5.68 |
| Resistance Level | $29.40 | $6.08 |
| Average True Range (ATR) | 1.13 | 0.37 |
| MACD | 0.27 | 0.02 |
| Stochastic Oscillator | 72.71 | 63.21 |
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.